How many tablets are there in a box of Bedaquiline/Snaery and how is the packaging?

Bedaquiline (Bedaquiline) is an innovative anti-tuberculosis drug specifically used to treat multidrug-resistant tuberculosis (MDR-TB). Developed by Johnson & Johnson, this drug is the first new prescription drug to target the mechanism of drug-resistant tuberculosis in the past 40 years, so it plays an important role in the global anti-tuberculosis system. Bedaquiline has various packaging specifications, aiming to meet the needs of different clinical treatment cycles and groups of people. Common specifications are 100mg×24 tablets and 100mg×188 tablets. Among them, the 24-piece package is mostly used for short-term initial stage or hospital distribution, while the 188-piece package is suitable for long-term treatment management, especially in multi-drug combination therapy, which can reduce the burden of frequent medication. Some regions also provide small-dose packaging of 20 mg, which is mainly used for children or low-weight patients to allow flexible dosage adjustment.

The outer packaging of medicines is usually designed as a moisture-proof bottle, and a desiccant is included in the bottle to ensure the stability of the medicine. Each medicine is an oval-shaped film-coated tablet, which is easy to swallow orally. Medicines need to be stored in a cool, dry environment at about 25°C, and avoid direct exposure to strong light. The batch number, expiry date and storage conditions are marked on the bottle, which complies with international drug management regulations. In some import channels, Snairi also provides packaging designs with child-proof lids to prevent the risk of accidental ingestion.

From the perspective of market circulation, China mainly purchases through formal import channels or specific pharmacies, and the packaging format is consistent with overseas. In India, Laos and other places, generic versions of Bedaquiline have also been launched. The packaging specifications are similar, but the price is relatively low, allowing patients with different economic conditions to choose. It is worth noting that regardless of the packaging form, bedaquiline must be purchased and used under a doctor's prescription. Because of its long course of treatment and possible risks such as prolongation of the QT interval in the electrocardiogram and fluctuations in liver function, patients should not adjust the dosage or change brands without authorization.

Reference materials:https://en.wikipedia.org/wiki/Bedaquiline